F, D. P., P, P., N, V., L, M., S, M., & G, M. (2013). Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Dove Medical Press.
Cita Chicago Style (17a ed.)F, Di Pierro, Putignano P, Villanova N, Montesi L, Moscatiello S, y Marchesini G. Preliminary Study About the Possible Glycemic Clinical Advantage in Using a Fixed Combination of Berberis Aristata and Silybum Marianum Standardized Extracts Versus Only Berberis Aristata in Patients with Type 2 Diabetes. Dove Medical Press, 2013.
Cita MLA (8a ed.)F, Di Pierro, et al. Preliminary Study About the Possible Glycemic Clinical Advantage in Using a Fixed Combination of Berberis Aristata and Silybum Marianum Standardized Extracts Versus Only Berberis Aristata in Patients with Type 2 Diabetes. Dove Medical Press, 2013.